Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study.
暂无分享,去创建一个
G. Lee | J. Ahn | K. Choi | Jeong Hoon Lee | D. Kim | H. Song | H. Na | K. Jung | Seol So | Nayoung Kim | H. Jung
[1] G. Lee,et al. Efficacy and safety of endoscopic submucosal dissection for gastric neoplasms in patients with compensated liver cirrhosis: a propensity score-matched case-control study. , 2018, Gastrointestinal endoscopy.
[2] M. Iwamuro,et al. Postoperative bleeding risk after gastric endoscopic submucosal dissection during antithrombotic drug therapy , 2018, Journal of gastroenterology and hepatology.
[3] F. Chan,et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines , 2018, Gut.
[4] K. Wijarnpreecha,et al. Heparin-Bridging Therapy and Risk of Bleeding After Endoscopic Submucosal Dissection for Gastric Neoplasms: a Meta-Analysis , 2018, Journal of Gastrointestinal Cancer.
[5] H. Park,et al. Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis , 2018, Digestive Diseases and Sciences.
[6] Xiaoping Zhou,et al. Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. , 2017, Gastrointestinal endoscopy.
[7] K. Hirasawa,et al. Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection , 2017, World journal of gastroenterology.
[8] Mary B Leonard,et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.
[9] M. Iwamuro,et al. Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection , 2017, Endoscopy International Open.
[10] D. Murakami,et al. Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study , 2017, Endoscopy International Open.
[11] H. Ono,et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection? , 2017, Surgical Endoscopy.
[12] H. Mashima,et al. Risk factors for postoperative bleeding after gastric endoscopic submucosal dissection in patients under antithrombotics. , 2016, World journal of gastrointestinal endoscopy.
[13] E. Knight,et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines , 2016, Gut.
[14] John A. Evans,et al. The management of antithrombotic agents for patients undergoing GI endoscopy. , 2016, Gastrointestinal endoscopy.
[15] G. Lee,et al. Risk factors and correlations of immediate, early delayed, and late delayed bleeding associated with endoscopic resection for gastric neoplasms , 2016, Surgical Endoscopy.
[16] G. Lee,et al. Delayed Bleeding Rate According to the Forrest Classification in Second-Look Endoscopy After Endoscopic Submucosal Dissection , 2015, Digestive Diseases and Sciences.
[17] K. Koike,et al. Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study , 2015, Endoscopy.
[18] D. Kikuchi,et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy , 2015, Gastric Cancer.
[19] Takuya Yamada,et al. Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis , 2015, Surgical Endoscopy.
[20] S. Tounou,et al. Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy , 2014, Endoscopy International Open.
[21] O. Yokosuka,et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents , 2014, BMC Gastroenterology.
[22] K. Chayama,et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in patients with chronic kidney disease , 2013, Journal of gastroenterology and hepatology.
[23] K. Higuchi,et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection , 2013, BMC Gastroenterology.
[24] S. Morita,et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. , 2013, Gastrointestinal endoscopy.
[25] Takuya Yamada,et al. Gastric ESD under Heparin Replacement at High-Risk Patients of Thromboembolism Is Technically Feasible but Has a High Risk of Delayed Bleeding: Osaka University ESD Study Group , 2013, Gastroenterology research and practice.
[26] Ji Won Kim,et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? , 2012, Gastrointestinal endoscopy.
[27] K. Hirata,et al. Analysis of Delayed Bleeding after Endoscopic Submucosal Dissection for Gastric Epithelial Neoplasms , 2012, Gastroenterology research and practice.
[28] I. Choi,et al. Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms , 2012, Endoscopy.
[29] K. Chayama,et al. RISK FACTORS FOR BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION OF GASTRIC EPITHELIAL NEOPLASM , 2011, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[30] G. Lee,et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. , 2011, Gastrointestinal endoscopy.
[31] N. Matsuhashi,et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. , 2010, World journal of gastroenterology.
[32] D. Graham,et al. Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions , 2009, Scandinavian journal of gastroenterology.
[33] G. Raskob,et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[34] M. Jung,et al. Predictors of immediate bleeding during endoscopic submucosal dissection in gastric lesions , 2008, Surgical Endoscopy.
[35] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.